These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 21544194

  • 1. Isolation and mutagenesis of a capsule-like complex (CLC) from Francisella tularensis, and contribution of the CLC to F. tularensis virulence in mice.
    Bandara AB, Champion AE, Wang X, Berg G, Apicella MA, McLendon M, Azadi P, Snyder DS, Inzana TJ.
    PLoS One; 2011 Apr 22; 6(4):e19003. PubMed ID: 21544194
    [Abstract] [Full Text] [Related]

  • 2. Further Characterization of the Capsule-Like Complex (CLC) Produced by Francisella tularensis Subspecies tularensis: Protective Efficacy and Similarity to Outer Membrane Vesicles.
    Champion AE, Bandara AB, Mohapatra N, Fulton KM, Twine SM, Inzana TJ.
    Front Cell Infect Microbiol; 2018 Apr 22; 8():182. PubMed ID: 29963499
    [Abstract] [Full Text] [Related]

  • 3. Glycosylation of a Capsule-Like Complex (CLC) by Francisella novicida Is Required for Virulence and Partial Protective Immunity in Mice.
    Freudenberger Catanzaro KC, Champion AE, Mohapatra N, Cecere T, Inzana TJ.
    Front Microbiol; 2017 Apr 22; 8():935. PubMed ID: 28611741
    [Abstract] [Full Text] [Related]

  • 4. A Francisella tularensis live vaccine strain (LVS) mutant with a deletion in capB, encoding a putative capsular biosynthesis protein, is significantly more attenuated than LVS yet induces potent protective immunity in mice against F. tularensis challenge.
    Jia Q, Lee BY, Bowen R, Dillon BJ, Som SM, Horwitz MA.
    Infect Immun; 2010 Oct 22; 78(10):4341-55. PubMed ID: 20643859
    [Abstract] [Full Text] [Related]

  • 5. Attenuation and protective efficacy of an O-antigen-deficient mutant of Francisella tularensis LVS.
    Li J, Ryder C, Mandal M, Ahmed F, Azadi P, Snyder DS, Pechous RD, Zahrt T, Inzana TJ.
    Microbiology (Reading); 2007 Sep 22; 153(Pt 9):3141-3153. PubMed ID: 17768257
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Identification of a live attenuated vaccine candidate for tularemia prophylaxis.
    Mahawar M, Rabadi SM, Banik S, Catlett SV, Metzger DW, Malik M, Bakshi CS.
    PLoS One; 2013 Sep 22; 8(4):e61539. PubMed ID: 23613871
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Identification of Francisella tularensis Himar1-based transposon mutants defective for replication in macrophages.
    Maier TM, Casey MS, Becker RH, Dorsey CW, Glass EM, Maltsev N, Zahrt TC, Frank DW.
    Infect Immun; 2007 Nov 22; 75(11):5376-89. PubMed ID: 17682043
    [Abstract] [Full Text] [Related]

  • 10. A Francisella tularensis locus required for spermine responsiveness is necessary for virulence.
    Russo BC, Horzempa J, O'Dee DM, Schmitt DM, Brown MJ, Carlson PE, Xavier RJ, Nau GJ.
    Infect Immun; 2011 Sep 22; 79(9):3665-76. PubMed ID: 21670171
    [Abstract] [Full Text] [Related]

  • 11. Global transcriptional response to mammalian temperature provides new insight into Francisella tularensis pathogenesis.
    Horzempa J, Carlson PE, O'Dee DM, Shanks RM, Nau GJ.
    BMC Microbiol; 2008 Oct 08; 8():172. PubMed ID: 18842136
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A defined O-antigen polysaccharide mutant of Francisella tularensis live vaccine strain has attenuated virulence while retaining its protective capacity.
    Sebastian S, Dillon ST, Lynch JG, Blalock LT, Balon E, Lee KT, Comstock LE, Conlan JW, Rubin EJ, Tzianabos AO, Kasper DL.
    Infect Immun; 2007 May 08; 75(5):2591-602. PubMed ID: 17296751
    [Abstract] [Full Text] [Related]

  • 15. Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis.
    KuoLee R, Harris G, Conlan JW, Chen W.
    Vaccine; 2007 May 10; 25(19):3781-91. PubMed ID: 17346863
    [Abstract] [Full Text] [Related]

  • 16. The D-alanyl-d-alanine carboxypeptidase enzyme is essential for virulence in the Schu S4 strain of Francisella tularensis and a dacD mutant is able to provide protection against a pneumonic challenge.
    Kijek TM, Mou S, Bachert BA, Kuehl KA, Williams JA, Daye SP, Worsham PL, Bozue JA.
    Microb Pathog; 2019 Dec 10; 137():103742. PubMed ID: 31513897
    [Abstract] [Full Text] [Related]

  • 17. An AraC/XylS Family Transcriptional Regulator Modulates the Oxidative Stress Response of Francisella tularensis.
    Marghani D, Ma Z, Centone AJ, Huang W, Malik M, Bakshi CS.
    J Bacteriol; 2021 Nov 05; 203(23):e0018521. PubMed ID: 34543107
    [Abstract] [Full Text] [Related]

  • 18. Francisella tularensis live vaccine strain folate metabolism and pseudouridine synthase gene mutants modulate macrophage caspase-1 activation.
    Ulland TK, Janowski AM, Buchan BW, Faron M, Cassel SL, Jones BD, Sutterwala FS.
    Infect Immun; 2013 Jan 05; 81(1):201-8. PubMed ID: 23115038
    [Abstract] [Full Text] [Related]

  • 19. Francisella tularensis Live Vaccine Strain deficient in capB and overexpressing the fusion protein of IglA, IglB, and IglC from the bfr promoter induces improved protection against F. tularensis respiratory challenge.
    Jia Q, Bowen R, Lee BY, Dillon BJ, Masleša-Galić S, Horwitz MA.
    Vaccine; 2016 Sep 22; 34(41):4969-4978. PubMed ID: 27577555
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.